Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1986-5-1
pubmed:abstractText
Serum concentrations of the CA 19-9 antigen were determined in 91 patients with pancreatic cancer and in 111 patients with benign pancreatic, biliary and hepatocellular diseases. The CA 19-9 concentration was above the cut-off limit (37 U ml-1) in 78% of the patients with pancreatic cancer and high levels (greater than 500 U ml-1) were seen in 56% of these patients. Elevated levels were also seen in benign diseases (22%), especially in patients with extrahepatic cholestasis (up to 440 U ml-1). Hepatocellular jaundice and pancreatitis were associated with normal values (84% of the patients), or with only slightly elevated CA 19-9 levels (up to 88 U ml-1). The CA 19-9 test can be useful as an additional diagnostic tool for the detection of pancreatic cancer. Preliminary results suggest that the CA 19-9 assay can be used in the monitoring of surgically treated patients.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-3513813, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-354771, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-6163212, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-6193872, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-6198342, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-6199316, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-6582896, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-6825270, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-7068815, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-7142214, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456787-94699
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
197-202
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't